These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11789435)

  • 1. [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].
    Homberg V; Kowalik A; Schulze-Bonhage A
    Nervenarzt; 2001 Dec; 72(12):918-23. PubMed ID: 11789435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
    Barcs G; Walker EB; Elger CE; Scaramelli A; Stefan H; Sturm Y; Moore A; Flesch G; Kramer L; D'Souza J
    Epilepsia; 2000 Dec; 41(12):1597-607. PubMed ID: 11114219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study].
    Steinhoff BJ; Stefan H; Schulze-Bonhage A; Hueber R; Paulus W; Wangemann M; Elger CE
    Nervenarzt; 2012 Oct; 83(10):1292-9. PubMed ID: 22850688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
    Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
    Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.
    Koch MW; Polman SK
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006453. PubMed ID: 19821367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
    Christe W; Krämer G; Vigonius U; Pohlmann H; Steinhoff BJ; Brodie MJ; Moore A
    Epilepsy Res; 1997 Mar; 26(3):451-60. PubMed ID: 9127726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine for epilepsy--a useful new choice?
    Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical recommendations for oxcarbazepine.
    Smith PE;
    Seizure; 2001 Mar; 10(2):87-91. PubMed ID: 11421225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
    Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
    Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oxcarbazepine and carbamazepine: a double-blind study.
    Reinikainen KJ; Keränen T; Halonen T; Komulainen H; Riekkinen PJ
    Epilepsy Res; 1987 Sep; 1(5):284-9. PubMed ID: 3504404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine in the treatment of childhood epilepsy.
    Serdaroglu G; Kurul S; Tutuncuoglu S; Dirik E; Sarioglu B
    Pediatr Neurol; 2003 Jan; 28(1):37-41. PubMed ID: 12657418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyponatremia from oxcarbazepine and carbamazepine.
    Dong X; Leppik IE; White J; Rarick J
    Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
    Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
    Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.